Literature DB >> 24422140

A bone to pick with zebrafish.

Eirinn W Mackay1, Alexander Apschner1, Stefan Schulte-Merker1.   

Abstract

The development of high-throughput sequencing and genome-wide association studies allows us to deduce the genetic factors underlying diseases much more rapidly than possible through classical genetics, but a true understanding of the molecular mechanisms of these diseases still relies on integrated approaches including in vitro and in vivo model systems. One such model that is particularly suitable for studying bone diseases is the zebrafish (Danio rerio), a small fresh-water teleost that is highly amenable to genetic manipulation and in vivo imaging. Zebrafish physiology and genome organization are in many aspects similar to those of humans, and the skeleton and mineralizing tissues are no exception. In this review, we highlight some of the contributions that have been made through the study of mutant zebrafish that feature bone and/or mineralization disorders homologous to human diseases, including osteogenesis imperfecta, fibrodysplasia ossificans progressiva and generalized arterial calcification of infancy. The genomic and phenotypic similarities between the zebrafish and human cases are illustrated. We show that, despite some systemic physiological differences between mammals and teleosts, and a relative lack of a history as a model for bone research, the zebrafish represents a useful complement to mouse and tissue culture systems in the investigation of genetic bone disorders.

Entities:  

Year:  2013        PMID: 24422140      PMCID: PMC3844975          DOI: 10.1038/bonekey.2013.179

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  35 in total

Review 1.  Procollagen trafficking, processing and fibrillogenesis.

Authors:  Elizabeth G Canty; Karl E Kadler
Journal:  J Cell Sci       Date:  2005-04-01       Impact factor: 5.285

2.  Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.

Authors:  Kathrin Laue; Hans-Martin Pogoda; Philip B Daniel; Arie van Haeringen; Yasemin Alanay; Simon von Ameln; Martin Rachwalski; Tim Morgan; Mary J Gray; Martijn H Breuning; Gregory M Sawyer; Andrew J Sutherland-Smith; Peter G Nikkels; Christian Kubisch; Wilhelm Bloch; Bernd Wollnik; Matthias Hammerschmidt; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2011-10-20       Impact factor: 11.025

3.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

4.  Cardiac morphology and blood pressure in the adult zebrafish.

Authors:  N Hu; H J Yost; E B Clark
Journal:  Anat Rec       Date:  2001-09-01

5.  Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish.

Authors:  P V Asharani; Katharina Keupp; Oliver Semler; Wenshen Wang; Yun Li; Holger Thiele; Gökhan Yigit; Esther Pohl; Jutta Becker; Peter Frommolt; Carmen Sonntag; Janine Altmüller; Katharina Zimmermann; Daniel S Greenspan; Nurten A Akarsu; Christian Netzer; Eckhard Schönau; Radu Wirth; Matthias Hammerschmidt; Peter Nürnberg; Bernd Wollnik; Thomas J Carney
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

6.  Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton.

Authors:  Kirsten M Spoorendonk; Josi Peterson-Maduro; Jörg Renn; Torsten Trowe; Sander Kranenbarg; Christoph Winkler; Stefan Schulte-Merker
Journal:  Development       Date:  2008-10-16       Impact factor: 6.868

7.  Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.

Authors:  Darren W Engers; Audrey Y Frist; Craig W Lindsley; Charles C Hong; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2013-04-11       Impact factor: 2.823

8.  Radiographic analysis of zebrafish skeletal defects.

Authors:  Shannon Fisher; Pudur Jagadeeswaran; Marnie E Halpern
Journal:  Dev Biol       Date:  2003-12-01       Impact factor: 3.582

9.  Using transgenic reporters to visualize bone and cartilage signaling during development in vivo.

Authors:  Chrissy L Hammond; Enrico Moro
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-18       Impact factor: 5.555

10.  Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Front Genet       Date:  2012-12-24       Impact factor: 4.599

View more
  26 in total

Review 1.  The genetics of bone mass and susceptibility to bone diseases.

Authors:  David Karasik; Fernando Rivadeneira; Mark L Johnson
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

2.  A role for G protein-coupled receptor 137b in bone remodeling in mouse and zebrafish.

Authors:  K Urso; J Caetano-Lopes; P Y Lee; J Yan; K Henke; M Sury; H Liu; M Zgoda; C Jacome-Galarza; P A Nigrovic; J Duryea; M P Harris; J F Charles
Journal:  Bone       Date:  2019-06-05       Impact factor: 4.398

3.  Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model.

Authors:  Tingsheng Yu; Christoph Winkler
Journal:  J Vis Exp       Date:  2017-01-01       Impact factor: 1.355

4.  Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.

Authors:  Charlotte Gistelinck; Paul Eckhard Witten; Ann Huysseune; Sofie Symoens; Fransiska Malfait; Daria Larionova; Pascal Simoens; Manuel Dierick; Luc Van Hoorebeke; Anne De Paepe; Ronald Y Kwon; MaryAnn Weis; David R Eyre; Andy Willaert; Paul J Coucke
Journal:  J Bone Miner Res       Date:  2016-10-24       Impact factor: 6.741

5.  Carbon dots: promising biomaterials for bone-specific imaging and drug delivery.

Authors:  Zhili Peng; Esmail H Miyanji; Yiqun Zhou; Joel Pardo; Sajini D Hettiarachchi; Shanghao Li; Patricia L Blackwelder; Isaac Skromne; Roger M Leblanc
Journal:  Nanoscale       Date:  2017-11-16       Impact factor: 7.790

6.  Zebrafish Bone and General Physiology Are Differently Affected by Hormones or Changes in Gravity.

Authors:  Jessica Aceto; Rasoul Nourizadeh-Lillabadi; Raphael Marée; Nadia Dardenne; Nathalie Jeanray; Louis Wehenkel; Peter Aleström; Jack J W A van Loon; Marc Muller
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

7.  Proteomics analysis of the zebrafish skeletal extracellular matrix.

Authors:  Maurijn Y Kessels; Leonie F A Huitema; Sjef Boeren; Sander Kranenbarg; Stefan Schulte-Merker; Johan L van Leeuwen; Sacco C de Vries
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE).

Authors:  Alexander Apschner; Leonie F A Huitema; Bas Ponsioen; Josi Peterson-Maduro; Stefan Schulte-Merker
Journal:  Dis Model Mech       Date:  2014-06-06       Impact factor: 5.758

9.  Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway.

Authors:  Mami Uemura; Ayumi Nagasawa; Kenta Terai
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

10.  Deep learning-based framework for cardiac function assessment in embryonic zebrafish from heart beating videos.

Authors:  Amir Mohammad Naderi; Haisong Bu; Jingcheng Su; Mao-Hsiang Huang; Khuong Vo; Ramses Seferino Trigo Torres; J-C Chiao; Juhyun Lee; Michael P H Lau; Xiaolei Xu; Hung Cao
Journal:  Comput Biol Med       Date:  2021-06-11       Impact factor: 4.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.